PMID- 32780655 OWN - NLM STAT- MEDLINE DCOM- 20210224 LR - 20210224 IS - 1557-9034 (Electronic) IS - 1092-6429 (Linking) VI - 30 IP - 10 DP - 2020 Oct TI - Anatomic Laparoscopic Liver Resection in the Scenario of the Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. PG - 1076-1081 LID - 10.1089/lap.2020.0562 [doi] AB - Aim: To assess the impact of the laparoscopic anatomic resections (LARs) on hepatocellular carcinoma (HCC) patients, analyzing the pooled short- and long-term outcomes of this technique and comparing it with the standard open approach [open anatomic resections (OAR)]. Material and Methods: A systematic literature search was performed in PubMed, Embase, and Scopus for studies published between 2010 and 2020 concerning LAR for HCC. Results: After screening 311 articles, 10 studies with a total of 398 patients who underwent LAR for HCC were included. The pooled cohort included mostly male (76.6%), Child A (98.2%), with hepatitis B virus (HBV)-related disease (60.5%). The pooled conversion rate was 7.3%. The pooled overall complication rate was 10.2 with a mortality rate of 1.0%. In the pooled analyses of only comparative studies, LAR group included 378 versus 455 in OAR. Operative time was longer in the LAR group (329 minutes versus 248; P = .001). Blood loss (179 versus 331 mL; P = .018) was lower in the LAR group. The pooled mean length of hospital stay was 8.4 days in LARs and 11.3 in OARs (P = .002). The pooled rate of postoperative complications was higher in the OAR group (25.3 versus 13.8; P = .009), while mortality rates were similar. The LAR group had a pooled 3- and 5-year overall survival of 90.1 and 81.9 versus 83.5 and 80.7 of the OARs (P > .05), respectively. Conclusions: In conclusion, the LAR for HCC is safe and associated with decreased blood loss and length of hospital stay. Survival rates are comparable with those of the conventional open approach. FAU - Solaini, Leonardo AU - Solaini L AD - Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy. AD - General and Oncologic Surgery, Morgagni-Pierantoni Hospital, AUSL Romagna, Forli, Italy. FAU - Bocchino, Antonio AU - Bocchino A AD - General and Oncologic Surgery, Morgagni-Pierantoni Hospital, AUSL Romagna, Forli, Italy. AD - Hepato-Pancreato-Biliary Surgery and Liver Transplantation Unit, University of Modena, Modena, Italy. FAU - Cucchetti, Alessandro AU - Cucchetti A AD - Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy. AD - General and Oncologic Surgery, Morgagni-Pierantoni Hospital, AUSL Romagna, Forli, Italy. FAU - Ercolani, Giorgio AU - Ercolani G AD - Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy. AD - General and Oncologic Surgery, Morgagni-Pierantoni Hospital, AUSL Romagna, Forli, Italy. LA - eng PT - Comparative Study PT - Journal Article PT - Meta-Analysis PT - Systematic Review DEP - 20200811 PL - United States TA - J Laparoendosc Adv Surg Tech A JT - Journal of laparoendoscopic & advanced surgical techniques. Part A JID - 9706293 SB - IM MH - Blood Loss, Surgical MH - Carcinoma, Hepatocellular/*surgery MH - Conversion to Open Surgery MH - Hepatectomy/adverse effects/*methods MH - Humans MH - *Laparoscopy/adverse effects MH - Length of Stay MH - Liver Neoplasms/*surgery MH - Operative Time MH - Postoperative Complications/etiology MH - Survival Rate MH - Treatment Outcome OTO - NOTNLM OT - anatomic resections OT - hepatocellular carcinoma OT - laparoscopy OT - meta-analysis OT - minimally invasive surgery OT - survival EDAT- 2020/08/12 06:00 MHDA- 2021/02/25 06:00 CRDT- 2020/08/12 06:00 PHST- 2020/08/12 06:00 [pubmed] PHST- 2021/02/25 06:00 [medline] PHST- 2020/08/12 06:00 [entrez] AID - 10.1089/lap.2020.0562 [doi] PST - ppublish SO - J Laparoendosc Adv Surg Tech A. 2020 Oct;30(10):1076-1081. doi: 10.1089/lap.2020.0562. Epub 2020 Aug 11.